TAYLOR CLIVE R 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Oct 23, 2003
Insider Transaction Report
Form 4
TAYLOR CLIVE R
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2003-10-21+350,000→ 2,072,000 totalExercise: $2.20Exp: 2013-10-20→ Common stock (350,000 underlying)
Holdings
- 19,000
Common Stock, $.001 par value
Footnotes (2)
- [F1]One-third of total shares subject to the option are exercisable on the date of grant; One-third of total shares subject to the option are exercisable on October 21, 2004 and; One-third of total shares subject to the option are exercisable on October 21, 2005.
- [F2]No price applies.